Cargando…
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection
There are limited data on outcomes of patients with prior Coronavirus disease 2019 (COVID-19) who proceeded to autologous or allogeneic hematopoietic cell transplantation (HCT). Whether these patients are more susceptible to poor outcomes and recurrence of COVID-19 is unknown. We report a retrospect...
Autores principales: | Shah, Nishi, Dahi, Parastoo B., Ponce, Doris M., Sauter, Craig S., Shaffer, Brian C., Chung, David J., Politikos, Ioannis, Lin, Richard J., Giralt, Sergio A., Papanicolaou, Genovefa, Ramanathan, Lakshmi V., Perales, Miguel-Angel, Kamboj, Mini, Shah, Gunjan L., Gyurkocza, Boglarka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503970/ https://www.ncbi.nlm.nih.gov/pubmed/34649021 http://dx.doi.org/10.1016/j.jtct.2021.10.004 |
Ejemplares similares
-
Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy
por: Infante, Maria Stefania, et al.
Publicado: (2022) -
595. Letermovir (LTV) for Secondary Cytomegalovirus (CMV) Prevention in High Risk Hematopoietic Cell Transplant (HCT) Recipients: Interim Results of a Single Center, Open Label Study
por: Han, Gyuri, et al.
Publicado: (2021) -
Humoral Response to COVID-19 Vaccination Given Pre-Cellular Therapy Wanes in Patients after Cellular Therapy: An Argument for Full Reimmunization
por: Shah, Gunjan L., et al.
Publicado: (2022) -
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
por: Nawas, Mariam T., et al.
Publicado: (2021) -
Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines
por: Tamari, Roni, et al.
Publicado: (2021)